PFIZER $29.09

down -0.02


24/5/2013 12:24 PM  |  NYSE : PFE  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : 29% - PFE has outperformed the S&P 500 by 4%

Get Trend Analysis Icon Get Trend Analysis

ETF Alternatives sponsored by



People viewing PFE also viewed: , , , ,

Competitors

Ticker Name Volume % Change
NGSX NEUROGESX; INC. COMMON STOCK 11.5K +0.49%
AIMM AUTOIMMUNE 500.0 +0.43%
GSTV GLOBAL STEVIA 10.0K +0.40%
ISLT ISLET SCIENCES 64.6K +0.39%
CNSO CNS RESPONSE 23.1K +0.36%

PFE Stock Analysis

  1. After A Big Rally, Pfizer Might Need Some Rest

    A big rally has brought Pfizer back to fair value.
  2. Amgen Chased By The Bubble

    Amgen really needs the pipeline to come through to support this valuation.
  3. The “Healthy” Play In Contract Research Organizations

    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane clinical trial and lab work. This outsourcing will be a big win for the contract research organizations.
Free Reports
  1. 3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
  2. Trading Systems at No Cost

    Get a FREE Magazine on the Top 10 Trading Systems.
  3. Stock Ideas From Warren Buffett

    Access Coattail Investor’s latest free report and get two investing ideas from Warren Buffett himself!
Marketplace
Trading Center